The Emboliner Embolic Protection System held its own in a recent head-to-head comparison with Boston Scientific’s Sentinel ...

Please provide your email address to receive an email when new articles are posted on . Stroke rates at 30 days after transcatheter aortic valve replacement were similar across a number of comparisons ...

Stroke remains a problem after TAVR and continues to feed discussions around how extensively cerebral embolic protection devices and other strategies should be used. In a session during TVT Connect, ...

Add Yahoo as a preferred source to see more of our stories on Google. I was one of the estimated 2.5 million Americans over the age of 75 with aortic stenosis, or AS, a hardening and narrowing of the ...

The largest study to date evaluating late neurological events after transcatheter aortic valve replacement (TAVR) has shown an increased rate of stroke and a very high rate of associated mortality in ...

(UPDATED) Full results of the secondary analysis looking at neurological events in the SURTAVI trial affirm that intermediate-risk patients who underwent TAVR with the self-expanding CoreValve ...

The FDA's decision follows a clinical assessment of the Emboliner, including the PROTECT H2H IDE study.

Patients who suffer a stroke during hospitalization for infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) have a dismal prognosis, with more than half dying during the ...

All-cause and cardiovascular mortality were similar for transaortic valve replacement compared to open-heart surgery in high-risk older patients at three years with no increased risk of stroke after ...

In analysis of more than 100,000 patients from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapies Registry who underwent transcatheter aortic valve ...

I was one of the estimated 2.5 million Americans over the age of 75 with aortic stenosis, or AS, a hardening and narrowing of the aortic valve — the primary valve that helps deliver blood through the ...